MAI CDMO Network | Search and find the CMO / CDMO you need

Small

Medium

Large

Investigational

Commercial (Phase IV)

Human

Veterinary

1 / low-hazard (PDE > 10,000 µg/day)

2 (PDE = 1,000 - 10,000 µg/day)

3 (PDE = 100 - 1,000 µg/day)

4 / HPAPI (PDE = 10 - 100 µg/day)

5 / HPAPI (PDE < 10 µg/day)

Lowest potential for abuse

Low potential for abuse

Lower potential for abuse

High potential for abuse & medical use

High potential for abuse & no medical use

Filtros aplicadosHigh potential for abuse & no medical use×High potential for abuse & medical use×Limpar Todos

Exibir 52 facilidades

Ordenar por:

Espanha

STE PRASFARMA

Citostáticos CMO/CDMO e produtos de alta potência.

Descubra as nossas instalações

OEB (Faixas de Exposição Ocupacional): 5 / HPAPI (PDE < 10 µg/day), 4 / HPAPI (PDE = 10 - 100 µg/day)

BSL (Nível de Segurança Biológica): 3, 4

SUBSTÂNCIAS CONTROLADAS: High potential for abuse & medical use

CONFORMIDADE: ICH, ISO, ANVISA (Brazil B-GMP), TITCK (Turkish Health Authorities), SFDA (Saudi Food & Drug Authority), NMPA (China GMP), EMA (EU GMP)

MERCADOS: EMA (EU), NMPA (China), ANVISA (Brazil), MHRA (UK), SFDA (Saudi Arabia), Turkish Health Authorities

SERVIÇOS: Logistics, Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Regulatory services, Packaging

REGIÃO: Europa

TAMANHO DO LOTE: Large, Small, Medium

USAR: Human

ÁREAS DE EXPERIÊNCIA TERAPÊUTICA (ATC): (L) Antineoplastic and immunomodulating agents

CATEGORIA / PRODUTO: FDF / MEDICAMENTOS